title: Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
abstract: We have reported that short calcitonin (CT) treatment of mature mouse osteoclast-like cells (OCLs) in culture induced prolonged down-regulation of the CT receptor (CTR) and desensitization to CT rechallenge, at the level of adenylate cyclase activity. In this study, we have extended those studies to examine the bone resorbing activity of OCLs pretreated with CT. OCLs, which formed on gelled type I collagen, were pretreated with salmon CT (sCT)(10(-9)M, 1 h) and 24 h later were replated onto plastic dishes or dentine slices after removal from the gel by collagenase digestion. The number and population of either mononuclear or multinuclear OCLs that adhere to either surface was not affected by sCT pretreatment. It was found that OCLs pretreated with sCT regained reduced but significant bone resorbing capacity, which was quantitated as the surface area resorbed by OCLs on dentine slices. However, compared with control, the number of resorption pits produced by sCT- pretreated OCLs was slightly reduced, and the total pit area was decreased by approximately 40-50%. The distribution of individual pit sizes was altered by sCT-pretreatment so that the number of larger pits was predominantly reduced, suggesting that short sCT treatment may produce a long lasting decrease in osteoclast mobility. sCT was able to inhibit bone resorption activity of CT-pretreated OCLs (ED50:10(-13)-10(-12)M). Importantly, the ED50 of sCT inhibition of bone resorption in sCT-pretreated OCLs was approximately 100-fold greater than for control, indicating resistance of the OCLs to CT rechallenge. Consistent with these results, treatment of OCLs with sCT greatly decreased the expression of CTR messenger RNA, whereas no significant effect was observed on the tartrate-resistant acid phosphatase messenger RNA expression, a marker of resorptive capacity of osteoclasts. These results indicate, therefore, that an important component of escape of osteoclastic resorption from CT inhibition is CT resistance of mature osteoclasts, which regain bone resorbing function.
authors.affiliation: St. Vincent's Institute of Medical Research, Melbourne, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Wada
authors.forename: N
authors.initials: N
authors.lastname: Udagawa
authors.forename: N
authors.initials: N
authors.lastname: Nagata
authors.forename: T J
authors.initials: TJ
authors.lastname: Martin
authors.forename: D M
authors.initials: DM
authors.lastname: Findlay
mesh_terms: D000818:Animals; D001483:Base Sequence; D002116:Calcitonin / Q000378:metabolism* / Q000494:pharmacology; D002478:Cells, Cultured; D015536:Down-Regulation; D004351:Drug Resistance; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D010010:Osteoclasts / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D011869:Radioligand Assay; D018003:Receptors, Calcitonin / Q000378:metabolism*
chemical_list: D012333:RNA, Messenger; D018003:Receptors, Calcitonin; D002116:Calcitonin